United States - English - NLM (National Library of Medicine)

shionogi inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen 375 mg - carefully consider the potential benefits and risks of naprelan®  tablets and other treatment options before deciding to use naprelan®  tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naprelan®  tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan®  is contraindicated in patients with known hypersensitivity to naproxen. naprelan®  should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions, and precautions- preexisting asthma). naprelan®  is contraindicated for the treatment of peri-operative pain in the setting of corona

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - monensin as monensin sodium; rice hulls or corn grits or soyabean run - oral powder, pre-mix - monensin as monensin sodium antiprotozoal active 100.0 g/kg; rice hulls or corn grits or soyabean run ungrouped other 1.0 qs kg - nutrition & metabolism - cattle | cattle - feedlot | dairy cattle | goat | heifer | pasture cattle | poultry | | beef | billy | bos indicus | bos taurus - bloat | eimeria bovis | eimeria spp. | eimeria zuernii | improve feed efficiency | improve reproductive performance | improvement of milk production | ketosis | prevention of coccidiosis | promote animal growth | acetonaemia | bloated | coccidiosis - prevention of | colic | eimeria acervulina | eimeria brunetti | eimeria maxima | eimeria mivati | eimeria necatrix | eimeria tenella | elevated ketones | feed conversion | finishing | frothy bloat | gas colic | growth promotion | growth rate | legume bloat | liveweight gain | non-clinical ketosis | weight gain

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 100.0 g/kg - antibiotic & related - cattle | pigs | poultry | poultry broilers (meat for human consum) | beef | boar | bos indicus | bos taurus | bovine | breeders - antibiotic - anti-infective | bacterial infection | ileitis | liver abscess | mineral and nutritional additive | necrotic enteritis | promote animal growth | abrasions | abscesses | acetonaemia | actinobacillosis | airsacculitis | amino acid supplement | amino acids | amoxycillin sensitive bacteria | antiseptic | associated with viral disease | avian mycoplasmas | blackhead | body odours | bone fragility | bone growth | bowed tendons | broad spectrum | burns | calcium supplement | cartilage strength | coccidiosis | coliform complex | conjunctivitis | copper deficiency | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | egg shell | endometritis | enteric diseases | enzootic pneumonia | fatty acid deficiency | fatty liver | feed conversion | feed efficiency | finishing | fungal infections | girth galls | glucose | gram negative organisms | gram positive organisms | grass tetany | growth promotion | growth rate | hepatotoxic drugs | hypocalcaemia | hypo

Israel - English - Ministry of Health

taro pharmaceutical industries ltd - triamcinolone - tablets - triamcinolone 4 mg - triamcinolone - triamcinolone - rheumatology: - active phases of systemic vasculitis: panarteritis nodosa (in patients with concomitant positive hepatitis b serology, the duration of treatment should be restricted to two weeks), polymyalgia rheumatica (pmr), pmr with giant cell arteritis, arteritis temporalis with acute visual loss;- active phases of systemic rheumatic disease: systemic lupus erythematosus, mixed connective tissue disease;- severe progressive forms of active rheumatoid arthritis, e.g. rapidly destructive forms and/or with extra-articular manifestations;- other forms of inflammatory rheumatic arthritis, provided that the severity of symptoms requires it and non-steroidal anti-inflammatory drugs (nsaids) cannot be used:spondylarthritis (ankylosing spondylitis with involvement of peripheral joints, psoriatic arthritis, enteropathic arthropathy with high inflammatory activity);- reactive forms of arthritis;- arthritis in sarcoidosis;- severe systemic form of juvenile idiopathic arthritis (still’s disease) or with iridocyclitis refractory to topical treatment.pulmonary and respiratory tract disorders: - bronchial asthma:for the long-term treatment of severe chronic asthma (category 4) and for treatment of exacerbations in adults and children.- chronic obstructive pulmonary disease (copd):for short-term treatment (max. 14 days) of exacerbations;- upper respiratory tract disorders:for short-term treatment of severe forms of allergic rhinitis in adults after failure of all other treatment alternatives, including topical glucocorticoids.dermatology: - oral initial treatment of extensive, severe, acute skin conditions responsive to glucocorticoids, such as: allergic skin disease (e.g. acute urticaria, contact dermatitis, drug eruption), atopic eczema (acute exacerbations or extensive weeping eczema), pemphigus vulgaris.nephrology: - minimal change glomerulonephritis;- extracapillary proliferative glomerulonephritis (rapidly progressive glomerulonephritis), generally in combination with cytostatics, tapering and ending treatment in goodpasture’s syndrome; for all other forms, long-term continuation of treatment;- idiopathic retroperitoneal fibrosis.

Israel - English - Ministry of Health

roche pharmaceuticals (israel) ltd - vemurafenib - film coated tablets - vemurafenib 240 mg - vemurafenib - vemurafenib - zelboraf is indicated for the treatment of brafv600 mutation-positive unresectable or metastatic melanoma.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 1 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Israel - English - Ministry of Health

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.